Literature DB >> 25884646

Toward Labeled Argininamide-Type NPY Y1 Receptor Antagonists: Identification of a Favorable Propionylation Site in BIBO3304.

Max Keller1, Lisa Schindler1, Günther Bernhardt1, Armin Buschauer1.   

Abstract

Aiming at molecular tools for the neuropeptide Y Y1 receptor (Y1 R), three types of derivatives of the argininamide-type Y1 R antagonist BIBO3304 were prepared by (i) propionylation at the guanidine group (3), (ii) substitution at the urea moiety with a propionamidobutyl residue (4), and (iii) replacement of ureidomethyl by a propionylaminomethyl group (5). With Ki and Kb values in the range of 1.5-4.3 nM, determined in binding and functional assays, and high selectivity for the Y1 R over the Y2 R, Y4 R, and Y5 R, compounds 4 and 5 were identified as promising candidates for radiolabeling by [(3) H]propionylation according to established protocols.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Acylguanidine; Argininamide; BIBO3304; NPY Y1 receptor antagonist; Neuropeptide Y

Mesh:

Substances:

Year:  2015        PMID: 25884646     DOI: 10.1002/ardp.201400427

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  1 in total

1.  In Search of NPY Y4R Antagonists: Incorporation of Carbamoylated Arginine, Aza-Amino Acids, or d-Amino Acids into Oligopeptides Derived from the C-Termini of the Endogenous Agonists.

Authors:  Kilian K Kuhn; Timo Littmann; Stefanie Dukorn; Miho Tanaka; Max Keller; Takeaki Ozawa; Günther Bernhardt; Armin Buschauer
Journal:  ACS Omega       Date:  2017-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.